Utility and correlation of known anticoagulation parameters in the management of pediatric ventricular assist devices.

AIM

To assess utility and correlation of known anticoagulation parameters in the management of pediatric ventricular assist device (VAD).

METHODS

Retrospective study of pediatric patients supported with a Berlin EXCOR VAD at a single pediatric tertiary care center during a single year.

RESULTS

We demonstrated associations between activated thromboplastin time (aPTT) and R-thromboelastography (R-TEG) values (rs = 0.65, < 0.001) and between anti-Xa assay and R-TEG values (rs = 0.54, < 0.001). The strongest correlation was seen between aPTT and anti-Xa assays (rs = 0.71, < 0.001). There was also a statistically significant correlation between platelet counts and the maximum amplitude of TEG (rs = 0.71, < 0.001). Importantly, there was no association between dose of unfractionated heparin and either measure of anticoagulation (aPTT, anti-Xa or R-TEG value).

CONCLUSION

This study suggests that while there is strong correlation between aPTT, anti-Xa assay and R-TEG values for patients requiring VAD support, there is a lack of relevant correlation between heparin dose and degree of effect. This raises concern as various guidelines continue to recommend using these parameters to titrate heparin therapy.